Looking At Bristol-Myers Squibb's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Bristol-Myers Squibb.

Looking at options history for Bristol-Myers Squibb BMY we detected 10 strange trades.

If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 60% with bearish.

From the overall spotted trades, 8 are puts, for a total amount of $634,193 and 2, calls, for a total amount of $55,396.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $62.5 to $75.0 for Bristol-Myers Squibb over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale trades within a strike price range from $62.5 to $75.0 in the last 30 days.

Bristol-Myers Squibb Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
BMY PUT SWEEP BEARISH 10/21/22 $75.00 $189.2K 1.9K 683
BMY PUT SWEEP BULLISH 12/16/22 $75.00 $154.2K 3.3K 317
BMY PUT SWEEP BEARISH 12/16/22 $70.00 $73.4K 1.9K 345
BMY PUT SWEEP BULLISH 01/20/23 $62.50 $56.0K 16.9K 400
BMY PUT SWEEP BEARISH 10/21/22 $75.00 $53.0K 1.9K 118

Where Is Bristol-Myers Squibb Standing Right Now?

  • With a volume of 5,243,429, the price of BMY is down -0.79% at $71.21.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 40 days.

What The Experts Say On Bristol-Myers Squibb:

  • Berenberg downgraded its action to Hold with a price target of $76
  • BMO Capital has decided to maintain their Outperform rating on Bristol-Myers Squibb, which currently sits at a price target of $94.
  • Atlantic Equities has decided to maintain their Overweight rating on Bristol-Myers Squibb, which currently sits at a price target of $87.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Bristol-Myers Squibb, Benzinga Pro gives you real-time options trades alerts.

Date of Trade
Strike Price
Posted In: OptionsMarketsBZI-UOA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!